The purpose of the session is to provide an update on imaging of chronic liver disease which is very prevalent in the United States. Grey-scale ultrasound findings of chronic diffuse liver disease and cirrhosis will be discussed. Because of the increased risk of hepatocellular carcinoma in patients with chronic liver disease, the role of surveillance ultrasound and use of contrast-enhanced ultrasound immediately after detection of a nodule will also be discussed. In addition, the session will focus on the importance of quantifying liver fibrosis in the patient with chronic liver disease, ultrasound elastography, magnetic resonance elastography and emerging technologies for the care of the patient with chronic liver disease. Developed in conjunction with the Society of Radiologists in Ultrasound.
Leslie Scoutt: None
Richard Barr: Speakers Bureau-Phillips Healthcare|Siemens Healthcare|SuperSonic Imagine; Research Grants-Phillips Healthcare|Siemens Healthcare|Hitachi Aloka Medical Ltd|Analogic|SuperSonic Imagine
Richard Ehman: Royalty Income-Mayo Clinic / Resoundant; Officer, Director-Resoundant: President, CEO, Equity holder; Research Grants-Resoundant
Anil Kurup: None
Stephanie Wilson: None
You must be logged in and own this session in order to post comments.